Daily US Times: An expected reduction in the UK’s coronavirus vaccine supply in April is partly due to a delay in a delivery from India of 5m Oxford doses.
The shipment has been held up by four weeks. The Oxford-AstraZeneca vaccine was produced by the Serum Institute of India.
UK Housing Secretary said neither a single factory nor a country was responsible for the vaccine delivery issues.
The Department of Health insists it is still on track to offer a first dose of the vaccine to all adults in the country by the end of July.
NHS England warned of a reduction in vaccine supply in the next month in a letter to local health organisations on Wednesday.
The government of Scotland said it was “seeking clarity” from the UK Vaccine Taskforce on future supplies, while the governments in Northern Ireland and Wales said they were examining how their own vaccine programmes could be affected.
“Five million doses had been delivered a few weeks ago to the UK and we will try to supply more later, based on the current situation and the requirement for the government immunisation programme in India,” a spokesperson for the Serum Institute said.
The original aim had been to deliver the next five million vaccine doses in March, according to a source cited by the BBC, that although t there was not a stipulated time for the delivery of the doses.
Mr Jenrick told that the UK government had learned of Covid vaccine supply issues “in the last few days”.
You may read: EU warns UK over Covid-19 vaccine exports